Amarin Corp Plc (AMRN)

[Whalatane]

IRYO. Repatha was launched back in 2015 I think ...so 4 yrs ahead of the R-IT indication
I was thinking of script growth this year .
Reaptha scripts seems to be increasing whereas Vascepa has stalled ....and Vascepa is a far easier drug ( and more effective ) to take ...I'm on both.
From the CC I believe KM was talking about " relaunching Vascepa in the US market " ...well if Vascepa had not failed to launch properly ....there would be no need to "relaunch "
Just my take
Kiwi